Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Gammopathy of Uncertain Significance”

138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 138 results

Not applicableUnknownNCT04727294
What this trial is testing

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more
HealthTree Foundation 1,500
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Not applicableLooking for participantsNCT03717844
What this trial is testing

Registry for Adults With Plasma Cell Disorders (PCD's)

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+6 more
UNC Lineberger Comprehensive Cancer Center 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07209371
What this trial is testing

Rifaximin Versus No Intervention for the Treatment of IgA Monoclonal Gammopathy of Undetermined Significance

Who this might be right for
IgA Monoclonal Gammopathy of Undetermined Significance
Fred Hutchinson Cancer Center 50
Large-scale testing (Phase 3)Study completedNCT00666211
What this trial is testing

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Vanderbilt-Ingram Cancer Center 98
Not applicableStudy completedNCT03119883
What this trial is testing

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificancePlasma Cell Myeloma
Mayo Clinic 35
Not applicableLooking for participantsNCT02726750
What this trial is testing

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT03046381
What this trial is testing

Tocilizumab in Patients With Schnitzler's Syndrome

Who this might be right for
Schnitzler's Syndrome
Karoline Krause 8
Early research (Phase 1)Study completedNCT00006362
What this trial is testing

PS-341 in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Mayo Clinic
Not applicableEnrolling By InvitationNCT06472830
What this trial is testing

Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) / Multiple Myeloma (MM) Among Unique Populations of Black People

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance
Mayo Clinic 1,000
Testing effectiveness (Phase 2)Study completedNCT00006219
What this trial is testing

Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic
Not applicableLooking for participantsNCT06539832
What this trial is testing

Intestinal Flora and Immunity in Monoclonal Gammopathy Patients

Who this might be right for
Multiple MyelomaMGUSGut Microbiota+2 more
Zhujiang Hospital 300
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Testing effectiveness (Phase 2)Ended earlyNCT00588822
What this trial is testing

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

Who this might be right for
Precancerous Condition
Mayo Clinic 21
Not applicableLooking for participantsNCT06870760
What this trial is testing

Pre-malignant States to Hematologic Malignancies in Firefighters

Who this might be right for
Clonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more
Wake Forest University Health Sciences 300
Large-scale testing (Phase 3)Study completedNCT00070382
What this trial is testing

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 14
Not applicableNot Yet RecruitingNCT06987708
What this trial is testing

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

Who this might be right for
Monoclonal Gammopathy of Uncertain SignificanceSmoldering Myeloma
Hackensack Meridian Health 67
Not applicableStudy completedNCT01955395
What this trial is testing

Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 93
Very early researchWithdrawnNCT03591614
What this trial is testing

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Who this might be right for
Monoclonal GammopathySmoldering MyelomaMyeloma
Case Comprehensive Cancer Center
Load More Results